Well, Digital Witness.....let's look at that. JMO of course, but, it would seem to me that we are a biotech company who wants to do much more than simply grow and sell MMJ. With Sams help we will do work with the compounds to derive and specify medications which are specific to the individual. That was in previous pr's as part of the plan. This would apply to MMJ as well as Hemp.
The fact that these things would fall under Health Canada's province and control especially with quality control for medications......I can easily see why the license would be of great value.
But, even past that. Unless we can get some relief pretty soon, then paying the bills on the investments we currently own is only an ongoing financial concern. I know bill filed the discountenance and I am positive he had a valid reason to do so. I was not privy to the why's of that, so I do not know the specifics of the arrangement, but, I am positive there was one, of some sort. We shall all see soon enough is my guess. Who knows what the amended rules for H/C will look like, or , how long to implement ?? It may be best to simply walk away and get overseas with new funding to begin again.
A lot to guess about at the current time. That will also change soon enough. GLTA JMO, of course.